3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Endometrial Neoplasms
4
Lymphedema
3
Neoplasms
2
Melanoma
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Suspected Central Nervous System Tumors
1
Stomach Neoplasms
1
Skull Base Neoplasms
1
Pediatric Patients With Solid Tumors
1
Mixed Tumor, Mesodermal
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Diseases
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholecystitis
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Paclitaxel
9
Carboplatin
6
Cisplatin
5
Hyperthermic Intraperitoneal Chemotherapy
4
Oxaliplatin
3
Fluorouracil
3
Cytoreduction Surgical Procedures
3
Bevacizumab
3
nintedanib
2
Mitomycin
2
Leucovorin
2
Laparoscopy
2
Gemcitabine
2
Folfox protocol
2
Docetaxel
2
vandetanib
1
talimogene laherparepvec
1
strattice
1
sodium thiosulfate
1
poly(I).poly(c12,U)
1
pembrolizumab
1
olaparib
1
nilotinib
1
liposomal doxorubicin
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
farletuzumab
1
enzastaurin
1
catumaxomab
1
birinapant
1
atezolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Peritoneal Neoplasms
×
Indocyanine Green
×
Clear all
No trials found.